piracetam has been researched along with Liver Cirrhosis, Alcoholic in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Liver Cirrhosis, Alcoholic: FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is an antiepileptic drug approved for use as adjunctive therapy in adults with partial-onset seizures." | 2.71 | Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests. ( Brockmöller, J; Coupez, R; Lochs, H; Roots, I; Thomsen, T; Wittstock, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabolla, DR | 1 |
| Harnois, DM | 1 |
| Meschia, JF | 1 |
| Brockmöller, J | 1 |
| Thomsen, T | 1 |
| Wittstock, M | 1 |
| Coupez, R | 1 |
| Lochs, H | 1 |
| Roots, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687] | 46 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period
| Intervention | number of drinks per treatment period (Mean) |
|---|---|
| All Subjects (n = 46) Placebo | 41.2 |
| All Subjects (n = 46) Levetiracetam | 45.4 |
1 trial available for piracetam and Liver Cirrhosis, Alcoholic
| Article | Year |
|---|---|
Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
Topics: Adult; Anticonvulsants; Caffeine; Humans; Kidney Function Tests; Levetiracetam; Lidocaine; Liver Cir | 2005 |
1 other study available for piracetam and Liver Cirrhosis, Alcoholic
| Article | Year |
|---|---|
Levetiracetam monotherapy for liver transplant patients with seizures.
Topics: Anticonvulsants; Hepatitis C; Humans; Levetiracetam; Liver Cirrhosis, Alcoholic; Liver Transplantati | 2003 |